Lazuardi Mochamad, Suharjono Suharjono, Chien Chi-Hsien, He Jie-Long, Lee Chi-Wen, Peng Chia-Kang, Sukmanadi Mohammad, Sugihartuti Rahmi, Maslachah Lilik
Sub-division Veterinary-Pharmacy, Faculty of Veterinary Medicine, Universitas Airlangga, Mulyorejo Road, 60115, Surabaya, Indonesia.
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Airlangga, Mulyorejo Road, 60115, Surabaya, Indonesia.
Vet World. 2022 Dec;15(12):2896-2902. doi: 10.14202/vetworld.2022.2896-2902. Epub 2022 Dec 21.
The flavonoids from mistletoe are thought to have antimicrobial action. This encouraging finding supports the benefits of medicinal plants as a substitute for synthetic antimicrobials, thus promoting healthy lifestyles. In contrast, it is known that the use of topical drug formulations made from flavonoids of mistletoe ( (L.) Miq. ) with Indonesian name, (BD) is required in skin cell irritation. This study aimed to assess the toxic effects of the flavonoid substances of BD, as an initial screening.
A myeloma cell line was cultured in Roswell Park Memorial Institute medium, and the Baby Hamster Kidney clone 12 (BHK) cell line was cultured in Dulbecco's Modified Eagle's Medium from stock (±9 × 10 cells/mL), and 1.2 mL of culture were distributed into each well of a microtiter plate. Subsequently, 0.2 mL of serially diluted flavonoid compounds (0.5-3 μg/mL) were added to 12 wells for each concentration, as trial groups (including control groups), followed by a 2-day incubation. Observations were performed based on the cytopathic effect (CPE) using an inverted microscope at a magnification of 100×.
Cytopathic effect was detected on the microtiter plate wells for the groups of myeloma and BHK cells at a flavonoid concentration of 0.5 μg/mL-3 μg/mL.
Flavonoid compounds from BD were safely used for topical treatment of cancer cells at a concentration <2.491 μg/mL, whereas for non-cancerous cells, a concentration <2.582 μg/mL was sufficient (p < 0.05).
槲寄生中的黄酮类化合物被认为具有抗菌作用。这一令人鼓舞的发现支持了药用植物作为合成抗菌剂替代品的益处,从而促进健康的生活方式。相比之下,已知在皮肤细胞刺激方面需要使用由印尼名为(BD)的槲寄生黄酮类化合物制成的局部药物制剂。本研究旨在评估BD黄酮类物质的毒性作用,作为初步筛选。
骨髓瘤细胞系在罗斯威尔公园纪念研究所培养基中培养,幼仓鼠肾克隆12(BHK)细胞系在杜尔贝科改良的伊格尔培养基中从原液(±9×10个细胞/毫升)开始培养,将1.2毫升培养物分配到微量滴定板的每个孔中。随后,将0.2毫升系列稀释的黄酮类化合物(0.5 - 3微克/毫升)添加到每个浓度的12个孔中,作为试验组(包括对照组),然后进行2天的孵育。使用倒置显微镜以100倍放大倍数基于细胞病变效应(CPE)进行观察。
在黄酮类化合物浓度为0.5微克/毫升 - 3微克/毫升时,在微量滴定板孔中检测到骨髓瘤细胞组和BHK细胞组的细胞病变效应。
BD中的黄酮类化合物在浓度<2.491微克/毫升时可安全用于癌细胞的局部治疗,而对于非癌细胞,浓度<2.582微克/毫升就足够了(p < 0.05)。